Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
Control4 Corporation (CTRL) | BofA Merrill Lynch/ Raymond James | $60.00 | n.a. | |||
Ellington Housing (TBA) | Deutsche Bank Securities/ Credit Suisse | $100.00 | n.a. | |||
Marrone Bio Innovations (MBII) | Jefferies/ Piper Jaffray | $60.00 | n.a. | |||
Santander Consumer USA Holdings (TBA) | TBA | $50.00 | n.a. | |||
YuMe (YUME) | Citigroup/ Deutsche Bank Securities | $65.00 | n.a. | |||
n.a. (not available) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
OncoMed Pharmaceuticals (OMED) | Jefferies/ Leerink Swann | 4.00 | $115.00 | 2-Stars | ||
Physicians Realty Trust (DOC) | Wunderlich Securities/ Oppenheimer/ Janney Montgomery Scott/ JMP Securities/ BB&T Capital Markets | 8.00 | $11.50 | $13.50 | $100.00 | 1-Star |
Stock Building Supply Holdings (STCK) | Goldman, Sachs/ Barclays/ Citigroup | $175.00 | n.a. | |||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of July 1, 2013 | Manager(s) | Offered | Raised | Price | 7/5/13 | Change |
None |